Kidney Care Community News

Following the launch of a joint task force dedicated to reassessing the inclusion of race in GFR estimations, the National Kidney Foundation and the American Society of Nephrology seek input from the broader kidney care community.

Kidney care has long been a particular pain point in the health care system, but reform is on the way.

Race may have little influence in determining an accurate eGFR when assessing patients for kidney disease, according to study results published in American Journal of Kidney Diseases.

Results of surveys conducted by the National Kidney Foundation and Lupus Research Alliance show significant gaps in education and communication among patients and physicians about lupus nephritis care.

The National Kidney Foundation has formed a partnership with RenalytixAI to improve kidney disease diagnosis and assessment in early stages of the disease.

Through an analysis of electronic health record data, researchers from Geisinger determined patients with kidney disease are more likely to be hospitalized with COVID-19 vs. patients with other preexisting conditions.

Study findings show Black men who receive hemodialysis in communities with a higher proportion of Black residents experience worse outcomes than those who receive treatments in communities with fewer Black residents.

The FDA has approved Alnylam Pharmaceuticals Inc.’s lumasiran, known as Oxlumo, for the treatment of primary hyperoxaluria type 1 in both adults and children.

The American Kidney Fund announced it is hosting a virtual event in which experts will discuss how “undiagnosed or misdiagnosed causes of kidney disease” may impact patients.

A study of patients who received dialysis at centers across the United States revealed no link between neighborhood food environment – including access to “healthy foods” and socioeconomic status – and hyperphosphatemia.